Over the past 25 years, the world has cut child mortality in half—saving millions of lives through vaccines, better nutrition, and basic healthcare. But there's a part of the story that's less optimistic. Every year, two million pregnancies end in stillbirth, and most of those losses are preventable.

I recently wrote about how stillbirths have been left out of global health progress. Stillbirth research has been chronically underfunded, and progress on stillbirths has fallen behind the rest of child mortality. The biggest gap is in detection: catching dangerous pregnancies early, in rural clinics where most pregnant women are actually being cared for.

The good news is that promising new tools can make a real impact. One of them is a portable retinal camera made by a medtech startup in India called Remidio, which can flag early signs of pre-eclampsia, gestational diabetes, and other conditions that drive stillbirth, using nothing more than a quick scan of the eye. It's the kind of low-cost, scalable innovation that gives me hope this is a problem we can finally make real progress on.